A double-blind placebo-controlled study of exenatide for the treatment of weight gain associated with olanzapine in overweight or obese adults with bipolar disorder, major depressive disorder, schizophrenia or schizoaffective disorder
These SCFAs can act on receptors (FFAR2 and FFAR3) on gut L-cells, which helps prompt natural GLP-1 release (Tolhurst et al., 2012)
Compounds such as BPC-157, TB-500, and KPV are frequently used to support musculoskeletal healing, gut repair, and inflammatory regulation
However, if the medication is being prescribed specifically to reduce cardiovascular risk, the request should be routed to the patients Part D plan instead of the Bridge
2024 doi: 10.1007/s12020-024-04112-8
Apelin is necessary for the maintenance of insulin sensitivity